Breast Cancer Update

Latest Episodes:

5-Minute Journal Club Issue 7 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer May 19, 2025

Show notes

Dr Rinath M Jeselsohn from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer.

CME information and select publications here.

Breast Cancer — Year in Review Series on Relevant New Datasets and Advances May 06, 2025

Show notes

Dr Rebecca Dent from National Cancer Centre Singapore and Dr Nancy Lin from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss important efficacy and safety data from 2024 related to the management of localized and advanced breast cancers.

CME information and select publications here.

For Oncology Nurses: Antibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings from the 2025 Annual ONS Congress Apr 26, 2025

Show notes

Dr Edward B Garon, Dr Tiffany A Traina, and nurse practitioners Ms Marianne J Davies and Ms Marissa Marti-Smith discuss the role of antibody-drug conjugates in the care of patients with breast and lung cancer and strategies to mitigate and manage treatment-emergent adverse events.

NCPD information and select publications here.

Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy Apr 25, 2025

Show notes

Dr Adam M Brufsky from the University of Pittsburgh discusses first-line treatment selection for patients with HR-positive metastatic breast cancer and preexisting medical conditions.

CME information and select publications here.

HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit Apr 21, 2025

Show notes

Clinical investigators discuss available data guiding the management of HER2-positive, triple-negative and localized breast cancer. 

CME information and select publications here.

HR-Positive Breast Cancer — Fourth Annual National General Medical Oncology Summit Apr 13, 2025

Show notes

Clinical investigators discuss available data guiding the management of hormone receptor-positive metastatic breast cancer.

CME information and select publications here.

Breast Cancer — An Interview with Dr Adrienne G Waks on Recent Trial Updates Apr 08, 2025

Show notes

Dr Adrienne G Waks from Dana-Farber Cancer Institute in Boston, Massachusetts, reviews recent trial updates and their significance for the management of breast cancer.

CME information and select publications here.

Neurofibromatosis Type 1 Plexiform Neurofibromas — An interview with Dr Christopher L Moertel Mar 28, 2025

Show notes

Dr Christopher L Moertel from the University of Minnesota in Minneapolis discusses the clinical presentation of and optimal management strategies for plexiform neurofibromas and malignancies associated with neurofibromatosis type 1.

CME information and select publications here.

HR-Positive Breast Cancer — An Interview with Dr Sara A Hurvitz on the Role of Endocrine-Based Therapy Mar 28, 2025

Show notes

Dr Sara A Hurvitz from the Fred Hutchinson Cancer Center in Seattle, Washington, summarizes data presented at the recent 2024 San Antonio Breast Cancer Symposium applicable to the management of HR-positive breast cancer.

CME information and select publications here.

5-Minute Journal Club Issue 6 with Dr Komal Jhaveri: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer Mar 22, 2025

Show notes

Dr Komal Jhaveri from Memorial Sloan Kettering Cancer Center in New York, New York, discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer.

CME information and select publications here.

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected